FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000476715> ?p ?o ?g. }

• W2000476715 endingPage "156" @default.
• W2000476715 startingPage "147" @default.
• W2000476715 abstract "Purpose The surgical excision of retinal vascular lesions including hemangioblastomas is rarely practiced. This study investigates the pathological characteristics of 4 patients (3 with von Hippel–Lindau [VHL] disease and 1 with a vasoproliferative retinal tumor) who underwent ocular tumor resection. von Hippel–Lindau is an autosomal dominant disease caused by a defect of the VHL tumor suppressor gene. The VHL protein is required for oxygen-dependent degradation of hypoxia-inducible factor 1α. This factor regulates vascular endothelial growth factor (VEGF) and the chemokine receptor CXCR4. Retinal hemangioblastoma is the most common tumor observed in VHL disease. We investigated the expression of CXCR4; its ligand, CXCL12/SDF-1α; VEGF; and the VHL gene in VHL disease–associated retinal hemangioblastomas. Design Interventional case series with immunohistological and molecular pathological analyses. Participants Immunohistochemistry and molecular pathology of the surgically excised retinal lesions were performed. Intervention Large retinal hemangioblastomas (1–3 disc diameters) and vasoproliferative tumors were resected surgically after laser photocoagulation in 4 patients. The excised tissues were snap frozen and evaluated by histology. Molecular pathology was performed for the VHL gene, and immunohistochemistry and molecular detection (reverse transcription polymerase chain reaction) were carried out for VEGF, CXCR4, and CXCL12. Main Outcome Measures Evaluation of clinical presentations and molecular pathology of the excised retinal lesions. Results Large retinal hemangioblastomas were resected successfully from the 3 VHL cases. Postoperatively, all patients were stable. Molecular analyses disclosed the loss of heterozygosity at the VHL allele locus in the VHL retinal hemangioblastomas but not in the vasoproliferative tumor. High levels of transcript and protein were found for VEGF and CXCR4, whereas low levels of CXCL12 mRNA were expressed in the retinal hemangioblastomas associated with VHL disease. In contrast, very low levels of VEGF and CXCR4 mRNA were detected in the vasoproliferative tumor. Furthermore, increased expression of VEGF and CXCR4 was detected in more active hemangioblastomas. Conclusions Surgical resection of large retinal hemangioblastomas may be useful for therapy in selected VHL patients. Activated VHL lesions produce more VEGF. This is the first demonstration of CXCR4 expression in VHL disease–associated retinal hemangioblastomas. We suggest targeting CXCR4 as an additional therapeutic strategy for VHL disease–associated retinal hemangioblastomas. The surgical excision of retinal vascular lesions including hemangioblastomas is rarely practiced. This study investigates the pathological characteristics of 4 patients (3 with von Hippel–Lindau [VHL] disease and 1 with a vasoproliferative retinal tumor) who underwent ocular tumor resection. von Hippel–Lindau is an autosomal dominant disease caused by a defect of the VHL tumor suppressor gene. The VHL protein is required for oxygen-dependent degradation of hypoxia-inducible factor 1α. This factor regulates vascular endothelial growth factor (VEGF) and the chemokine receptor CXCR4. Retinal hemangioblastoma is the most common tumor observed in VHL disease. We investigated the expression of CXCR4; its ligand, CXCL12/SDF-1α; VEGF; and the VHL gene in VHL disease–associated retinal hemangioblastomas. Interventional case series with immunohistological and molecular pathological analyses. Immunohistochemistry and molecular pathology of the surgically excised retinal lesions were performed. Large retinal hemangioblastomas (1–3 disc diameters) and vasoproliferative tumors were resected surgically after laser photocoagulation in 4 patients. The excised tissues were snap frozen and evaluated by histology. Molecular pathology was performed for the VHL gene, and immunohistochemistry and molecular detection (reverse transcription polymerase chain reaction) were carried out for VEGF, CXCR4, and CXCL12. Evaluation of clinical presentations and molecular pathology of the excised retinal lesions. Large retinal hemangioblastomas were resected successfully from the 3 VHL cases. Postoperatively, all patients were stable. Molecular analyses disclosed the loss of heterozygosity at the VHL allele locus in the VHL retinal hemangioblastomas but not in the vasoproliferative tumor. High levels of transcript and protein were found for VEGF and CXCR4, whereas low levels of CXCL12 mRNA were expressed in the retinal hemangioblastomas associated with VHL disease. In contrast, very low levels of VEGF and CXCR4 mRNA were detected in the vasoproliferative tumor. Furthermore, increased expression of VEGF and CXCR4 was detected in more active hemangioblastomas. Surgical resection of large retinal hemangioblastomas may be useful for therapy in selected VHL patients. Activated VHL lesions produce more VEGF. This is the first demonstration of CXCR4 expression in VHL disease–associated retinal hemangioblastomas. We suggest targeting CXCR4 as an additional therapeutic strategy for VHL disease–associated retinal hemangioblastomas." @default.
• W2000476715 created "2016-06-24" @default.
• W2000476715 creator A5042897178 @default.
• W2000476715 creator A5055348574 @default.
• W2000476715 creator A5073456146 @default.
• W2000476715 creator A5074840368 @default.
• W2000476715 creator A5075848637 @default.
• W2000476715 creator A5082139259 @default.
• W2000476715 creator A5083375915 @default.
• W2000476715 date "2007-01-01" @default.
• W2000476715 modified "2023-10-16" @default.
• W2000476715 title "Molecular Pathology and CXCR4 Expression in Surgically Excised Retinal Hemangioblastomas Associated with von Hippel–Lindau Disease" @default.
• W2000476715 cites W1531662800 @default.
• W2000476715 cites W1541008751 @default.
• W2000476715 cites W1596162488 @default.
• W2000476715 cites W1698416416 @default.
• W2000476715 cites W1963984954 @default.
• W2000476715 cites W1964382251 @default.
• W2000476715 cites W1980475208 @default.
• W2000476715 cites W1985186861 @default.
• W2000476715 cites W1986887329 @default.
• W2000476715 cites W1988651185 @default.
• W2000476715 cites W1990842966 @default.
• W2000476715 cites W1991576108 @default.
• W2000476715 cites W1992954334 @default.
• W2000476715 cites W2001170648 @default.
• W2000476715 cites W2003502792 @default.
• W2000476715 cites W2005975965 @default.
• W2000476715 cites W2006535329 @default.
• W2000476715 cites W2008897960 @default.
• W2000476715 cites W2017686473 @default.
• W2000476715 cites W2018885286 @default.
• W2000476715 cites W2027410762 @default.
• W2000476715 cites W2028400858 @default.
• W2000476715 cites W2029799544 @default.
• W2000476715 cites W2031013001 @default.
• W2000476715 cites W2038416809 @default.
• W2000476715 cites W2057055394 @default.
• W2000476715 cites W2058554403 @default.
• W2000476715 cites W2058862357 @default.
• W2000476715 cites W2063562511 @default.
• W2000476715 cites W2071672972 @default.
• W2000476715 cites W2089220973 @default.
• W2000476715 cites W2090310262 @default.
• W2000476715 cites W2094857036 @default.
• W2000476715 cites W2095354110 @default.
• W2000476715 cites W2130007597 @default.
• W2000476715 cites W2131152822 @default.
• W2000476715 cites W2131525061 @default.
• W2000476715 cites W2141837666 @default.
• W2000476715 cites W2145861826 @default.
• W2000476715 cites W2146889332 @default.
• W2000476715 cites W2155028684 @default.
• W2000476715 cites W2156323704 @default.
• W2000476715 cites W2166005929 @default.
• W2000476715 cites W2234677840 @default.
• W2000476715 cites W2264958941 @default.
• W2000476715 cites W2400487552 @default.
• W2000476715 cites W2405530468 @default.
• W2000476715 cites W2551569844 @default.
• W2000476715 cites W3023174345 @default.
• W2000476715 cites W4234041062 @default.
• W2000476715 cites W4246476340 @default.
• W2000476715 cites W4297119881 @default.
• W2000476715 cites W67923160 @default.
• W2000476715 cites W75909359 @default.
• W2000476715 doi "https://doi.org/10.1016/j.ophtha.2006.05.068" @default.
• W2000476715 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2147685" @default.
• W2000476715 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17070589" @default.
• W2000476715 hasPublicationYear "2007" @default.
• W2000476715 type Work @default.
• W2000476715 sameAs 2000476715 @default.
• W2000476715 citedByCount "38" @default.
• W2000476715 countsByYear W20004767152012 @default.
• W2000476715 countsByYear W20004767152014 @default.
• W2000476715 countsByYear W20004767152015 @default.
• W2000476715 countsByYear W20004767152016 @default.
• W2000476715 countsByYear W20004767152017 @default.
• W2000476715 countsByYear W20004767152018 @default.
• W2000476715 countsByYear W20004767152019 @default.
• W2000476715 countsByYear W20004767152020 @default.
• W2000476715 countsByYear W20004767152021 @default.
• W2000476715 countsByYear W20004767152022 @default.
• W2000476715 countsByYear W20004767152023 @default.
• W2000476715 crossrefType "journal-article" @default.
• W2000476715 hasAuthorship W2000476715A5042897178 @default.
• W2000476715 hasAuthorship W2000476715A5055348574 @default.
• W2000476715 hasAuthorship W2000476715A5073456146 @default.
• W2000476715 hasAuthorship W2000476715A5074840368 @default.
• W2000476715 hasAuthorship W2000476715A5075848637 @default.
• W2000476715 hasAuthorship W2000476715A5082139259 @default.
• W2000476715 hasAuthorship W2000476715A5083375915 @default.
• W2000476715 hasBestOaLocation W20004767152 @default.
• W2000476715 hasConcept C104317684 @default.
• W2000476715 hasConcept C118487528 @default.
• W2000476715 hasConcept C126322002 @default.
• W2000476715 hasConcept C129470790 @default.
• W2000476715 hasConcept C13373296 @default.

• next